Thermo Fisher Scientific
TMO
1,135 hedge funds and large institutions have $52.8B invested in Thermo Fisher Scientific in 2017 Q1 according to their latest regulatory filings, with 90 funds opening new positions, 413 increasing their positions, 475 reducing their positions, and 55 closing their positions.
64% more first-time investments, than exits
New positions opened: 90 | Existing positions closed: 55
8% more funds holding in top 10
Funds holding in top 10: 60 → 65 (+5)
8% more capital invested
Capital invested by funds: $48.7B → $52.8B (+$4.03B)
2% more funds holding
Funds holding: 1,113 → 1,135 (+22)
0.59% more ownership
Funds ownership: 87.34% → 87.93% (+0.59%)
13% less repeat investments, than reductions
Existing positions increased: 413 | Existing positions reduced: 475
26% less call options, than puts
Call options by funds: $125M | Put options by funds: $169M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.39B |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
+$295M |
| 3 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$271M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$194M |
| 5 |
VAM
Veritas Asset Management
London,
United Kingdom
|
+$175M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
-$196M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$188M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$154M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$136M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
-$124M |
TMO Hedge Fund Activity: Q1 2017 in Review
1,135 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2017, worth a combined $52.8B — up 8.3% from $48.7B a quarter earlier.
Buyers outnumbered sellers: 90 funds opened new TMO positions and 55 closed out — a net gain of 35 holders — while 413 added to existing stakes and 475 trimmed.
The largest buyer was BlackRock, adding an estimated $3.39B. The largest seller was Temasek Holdings, cutting an estimated $196M.
- 1,135 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2017, up from 1,113 in Q4 2016.
- Funds reported $52.8B of Thermo Fisher Scientific stock for Q1 2017, up 8.3% quarter-over-quarter.
- 90 funds opened new Thermo Fisher Scientific positions in Q1 2017 and 55 closed out, a net change of +35 holders.
- The largest Thermo Fisher Scientific buyer in Q1 2017 was BlackRock, an estimated $3.39B added.
- The largest Thermo Fisher Scientific seller in Q1 2017 was Temasek Holdings, an estimated $196M sold.
Based on aggregated 13F filings for Q1 2017.